Results for “”

Entry Author Date Location
Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk 12/13/19 New York
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug 12/13/19 Boston
miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal 12/12/19 Boulder/Denver
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning 12/12/19 National
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy 12/12/19 San Diego
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink 12/11/19 National
Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics 12/11/19 Boston
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test 12/10/19 Boston
Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules 12/10/19 National
Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer 12/10/19 San Diego
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego’s Synthorx 12/09/19 San Diego
Aurinia Plans FDA Filing After Lupus Nephritis Drug Hits Phase 3 Goals 12/09/19 National
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule 12/09/19 New York
BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs 12/09/19 San Francisco
Insitro Hires Serafim Batzoglou As Its First Chief Data Officer 12/09/19 San Diego
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets 12/09/19 Boston
3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug 12/06/19 San Diego
Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis 12/06/19 San Diego
FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal 12/06/19 National
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results 12/05/19 National
FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder 12/05/19 Boston
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60% 12/05/19 Boston
As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug 12/05/19 San Diego
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost 12/04/19 New York
Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding 12/04/19 Boston
FDA Green Lights Sight Diagnostics’ Finger-Prick Blood Test 12/04/19 National
Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption 12/04/19 Raleigh Durham
Page 1 of 1955 next page »

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.